share_log

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%), etc.

Addex Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(15.1%),New Enterprise Associates 15, L.P.(15.1%)等

美股SEC公告 ·  2022/08/24 05:18

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。